The Role of Adjuvant Therapy in Duodenal Adenocarcinoma and Intestinal Subtype Ampullary Carcinoma after Curative Resection

医学 旁侵犯 辅助治疗 腺癌 胃肠病学 内科学 佐剂 围手术期 总体生存率 外科 肿瘤科 癌症
作者
Sarah Finton,Louisa Bolm,Martina Nebbia,Natalie Petruch,C Fernandez-del Castillo,Motaz Qadan,Keith D. Lillemoe,Ulrich F. Wellner,Marius Distler,Carolin Zimmermann,Jürgen Weitz,Felix Rückert,Nuh N. Rahbari,Christoph Reißfelder,Gennaro Nappo,Tobias Keck,Alessandro Zerbi,Cristina R. Ferrone
出处
期刊:Annals of Surgery [Lippincott Williams & Wilkins]
卷期号:280 (6): 986-992
标识
DOI:10.1097/sla.0000000000006129
摘要

Objective: To define the role of adjuvant therapy in duodenal adenocarcinoma (DAC) and intestinal subtype ampullary carcinoma (iAC). Background: DAC and iAC share a similar histologic differentiation but the benefit of adjuvant therapy remains unclear. Methods: Patients undergoing curative intent surgical resection for DAC and iAC between 2010 and 2021 at 5 high-volume centers were included. Patient baseline, perioperative, and long-term oncological outcomes were evaluated. Statistical testing was performed with SPSS 25 (IBM). Results: A total of 136 patients with DAC and 171 with iAC were identified. Patients with DAC had more advanced tumors than those with iAC. Median overall survival (OS) in patients with DAC was 101 months versus 155 months for patients with iAC ( P = 0.098). DAC had a higher rate of local (14.1% vs 1.2%, P < 0.001) and systemic recurrence (30.4% vs 3.5%, P < 0.001). Adjuvant therapy failed to improve OS in all patients with DAC and iAC. For DAC, patients with perineural invasion, but not other negative prognostic factors, had improved OS rates with adjuvant therapy (72 vs 44 m, P = 0.044). Patients with iAC with N+ (190 vs 57 m, P = 0.003), T3-T4 (177 vs 59 m, P = 0.050), and perineural invasion (150 vs 59 m, P = 0.019) had improved OS rates with adjuvant therapy. Conclusions: While adjuvant therapy fails to improve OS in all patients with DAC and iAC in the current study, it improved OS in patients with DAC with perineural invasion and in patients with iAC with T3-T4 tumors, positive lymph nodes, and perineural invasion.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小费发布了新的文献求助200
刚刚
在水一方应助yuhuan采纳,获得50
刚刚
要减肥的鸭胗完成签到,获得积分10
刚刚
hbutsj完成签到,获得积分10
刚刚
1秒前
酷波er应助xxxxx采纳,获得10
1秒前
1秒前
BINGBING1230发布了新的文献求助100
2秒前
朱朱朱完成签到,获得积分10
2秒前
科目三应助笨笨的仙人掌采纳,获得10
2秒前
乐乐应助cute666采纳,获得10
2秒前
王怡发布了新的文献求助10
3秒前
gqp完成签到,获得积分10
3秒前
浮浮世世发布了新的文献求助10
3秒前
3秒前
赵念婉完成签到,获得积分10
4秒前
5秒前
英吉利25发布了新的文献求助10
6秒前
星辰大海应助WB采纳,获得10
6秒前
花开富贵完成签到,获得积分10
6秒前
6秒前
6秒前
852应助凉雨街采纳,获得10
7秒前
樱桃味的火苗完成签到,获得积分10
7秒前
许晴发布了新的文献求助10
7秒前
8R60d8应助爱笑的雪糕采纳,获得10
8秒前
8秒前
8秒前
所所应助bixun采纳,获得10
8秒前
李爱国应助ppapp采纳,获得10
8秒前
飞鸿影下完成签到 ,获得积分10
9秒前
勤恳的一斩完成签到,获得积分10
9秒前
豆豆完成签到,获得积分10
9秒前
9秒前
dongdongqiang完成签到,获得积分10
10秒前
鹤雪完成签到,获得积分20
10秒前
阿北完成签到,获得积分10
10秒前
11秒前
简柠完成签到,获得积分10
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
网络安全 SEMI 标准 ( SEMI E187, SEMI E188 and SEMI E191.) 1000
计划经济时代的工厂管理与工人状况(1949-1966)——以郑州市国营工厂为例 500
INQUIRY-BASED PEDAGOGY TO SUPPORT STEM LEARNING AND 21ST CENTURY SKILLS: PREPARING NEW TEACHERS TO IMPLEMENT PROJECT AND PROBLEM-BASED LEARNING 500
Why America Can't Retrench (And How it Might) 400
Two New β-Class Milbemycins from Streptomyces bingchenggensis: Fermentation, Isolation, Structure Elucidation and Biological Properties 300
Modern Britain, 1750 to the Present (第2版) 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 催化作用 遗传学 冶金 电极 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 4614581
求助须知:如何正确求助?哪些是违规求助? 4018748
关于积分的说明 12439646
捐赠科研通 3701503
什么是DOI,文献DOI怎么找? 2041241
邀请新用户注册赠送积分活动 1073983
科研通“疑难数据库(出版商)”最低求助积分说明 957639